🇺🇸 FDA
Patent

US 8012976

Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)

granted A61KA61K31/282A61K31/4745

Quick answer

US patent 8012976 (Dihydropyridophthalazinone inhibitors of poly(ADP-ribose)polymerase (PARP)) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Sep 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/282, A61K31/4745, A61K31/495, A61K31/5025